Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02587390Phase 1Completed
Phase 1, open-label trial of gemcabene in hypercholesterolemia (2 arms), sponsored by NeuroBo Pharmaceuticals. Primary endpoint: Pharmacokinetics at 15 days. Started May 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02587390.